NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis $0.95 0.00 (0.00%) As of 10/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsNews and TrendsSEC Filings About Global Cord Blood Stock (NYSE:CO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Global Cord Blood alerts:Sign Up Key Stats Today's Range$0.95▼$0.9550-Day Range$0.95▼$0.9552-Week Range$2.03▼$5.50Volume2,530 shsAverage Volume216,519 shsMarket Capitalization$115.60 millionP/E Ratio1.49Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Global Cord Blood Corporation (NYSE: CO) was a China-based biotechnology and healthcare services company focused on umbilical cord blood banking. Through its operations, the company collected, tested, processed and stored umbilical cord blood for potential use in hematopoietic stem-cell transplantation and related medical applications. The company provided cord blood preservation services for families, along with laboratory testing, donor-recipient matching and support services associated with cord blood transplantation. Its cord blood banks served customers in selected regions of China, including Beijing, Guangdong province and Zhejiang province, through licensed banking and processing facilities. Global Cord Blood was formerly known as China Cord Blood Corporation and adopted its Global Cord Blood name in 2020. The business was established in the early 2000s and became publicly listed in the United States in 2009. Publicly available information about its current leadership and operating status is limited, and the company has undergone significant corporate changes since its period as a NYSE-listed issuer.AI Generated. May Contain Errors. Read More Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CO Stock News HeadlinesBBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to PatientsJuly 7, 2026 | usatoday.comStem Cell Banking Market Size to Hit USD 31.58 Billion by 2035 with 12.22% CAGR | SNS InsiderJuly 2, 2026 | finance.yahoo.comElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men described the same moment in strikingly similar terms: a technological tipping point they call the Singularity. James Altucher says the idea once belonged to science fiction. Now he connects it to a move Musk could make as soon as October 21, and lays out what both men see coming in a short presentation.October 16 at 1:00 AM | Paradigm Press (Ad)Global Cord Blood CorpMay 14, 2026 | cnbc.comKidde Enhances Carbon Monoxide (CO) Detection with Advanced Low-Level AlarmsMay 5, 2026 | businesswire.com$100+ Bn Cord Blood Banking Services Market - Global Forecast 2026-2032: Market is Evolving in Response to Technology Innovation, Regulatory Demands, and New Partnership ModelsFebruary 17, 2026 | uk.finance.yahoo.comStemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte(R) (HPC, Cord Blood) to Address Unmet Need in Long COVIDJanuary 26, 2026 | marketwatch.comUnlocking the Potential: Cord Blood Banking Services Market Projected to Surge by 2030December 10, 2025 | finance.yahoo.comSee More Headlines CO Stock Analysis - Frequently Asked Questions How have CO shares performed this year? Global Cord Blood's stock was trading at $0.95 at the beginning of 2026. Since then, CO shares have increased by 0.1% and is now trading at $0.9510. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) posted its quarterly earnings data on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some other companies that Global Cord Blood investors own include Riot Platforms (RIOT), Barrick Mining (B), Alibaba Group (BABA), Pfizer (PFE), Canopy Growth (CGC), Cronos Group (CRON) and Inseego (INSG). Company Calendar Last Earnings6/26/2018Today10/16/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolNYSE:CO CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.49 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.09 Cash Flow$0.23 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.15Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$115.60 million OptionableNo Data Beta0.16 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:CO) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA simple options strategy that changed one trader's pathIan Cooper went from a financially stressed, struggling journalist to a trader who discovered a repeatable opt...TradeWins | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
